Table 2.
Toxicity related to AHSCT
| Number (%) | WHO toxicity grade | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||
| Gut toxicity | 24 (63.1) | 10 | 12 | 2 | 0 |
| Skin toxicity | 18 (47.3) | 11 | 5 | 2 | 0 |
| Mucositis | 17 (44.7) | 11 | 6 | 0 | 0 |
| Hepatic toxicity | 15 (39.4) | 7 | 4 | 0 | 4 |
| Others | 8 (21.0) | 6 | 2 | 0 | 0 |
| Neurologic toxicity | 5 (13.1) | 4 | 1 | 0 | 0 |
| Coagulation toxicity | 4 (10.5) | 3 | 1 | 0 | 0 |
| Urologic toxicity | 2 (5.2) | 1 | 1 | 0 | 0 |
| Lung toxicity | 2 (5.2) | 1 | 1 | 0 | 0 |
| Endocrine toxicity | 2 (5.2) | 1 | 1 | 0 | 0 |
| Cardiac rhythm toxicity | 1 (2.6) | 1 | 0 | 0 | 0 |
| Cardiac function toxicity | 0 | 0 | 0 | 0 | 0 |
| Renal toxicity | 0 | 0 | 0 | 0 | 0 |
| WHO secondary adverse events | 98 | 56 | 34 | 4 | 4 |